Zynex Inc (ZYXI):企業の財務・戦略的SWOT分析

◆英語タイトル:Zynex Inc (ZYXI) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH34280FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥68,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥102,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Zynex Inc (Zynex) formerly Zynex Medical Inc operates as a medical technology company that designs, manufactures, and markets electrotherapy medical devices used for pain management and rehabilitation. The company’s products include NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular elect2ical stimulation device; and NeuroMove, an electromyography triggered electrical stimulation device; and InWave, an electrical stimulation product for the treatment of female urinary incontinence. It also offers Comfortrac for cervical traction; JetStream for hot and cold therapy; and Aspen LSO Back Braces for lumbar support. Zynex offers products for home use, cardiac monitoring and EMG and EEG diagnostic purposes in the neurology clinical market. The company markets its products through a network of medical distributors. Zynex is headquartered in Englewood, Colorado, the US.

Zynex Inc Key Recent Developments

Feb 25,2021: Zynex announces 2020 fourth quarter and full year earnings
Feb 18,2021: Zynex Schedules 2020 Fourth Quarter and Full-Year Earnings Call
Jan 28,2021: Zynex appoints Anna Lucsok as Chief Operating Officer of Zynex Medical
Jan 14,2021: Zynex announces filing of patent for sepsis monitor
Jan 12,2021: Zynex announces 117% year over year order growth and increases adjusted EBITDA estimate

This comprehensive SWOT profile of Zynex Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Zynex Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Zynex Inc – Key Information
Zynex Inc – Overview
Zynex Inc – Key Employees
Zynex Inc – Key Employee Biographies
Zynex Inc – Key Operational Heads
Zynex Inc – Major Products and Services
Zynex Inc – History
Zynex Inc – Company Statement
Zynex Inc – Locations And Subsidiaries
Zynex Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Zynex Inc – Business Description
Zynex Inc – Corporate Strategy
Zynex Inc – SWOT Analysis
SWOT Analysis – Overview
Zynex Inc – Strengths
Zynex Inc – Weaknesses
Zynex Inc – Opportunities
Zynex Inc – Threats
Zynex Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Zynex Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Zynex Inc, Key Information
Zynex Inc, Key Ratios
Zynex Inc, Share Data
Zynex Inc, Major Products and Services
Zynex Inc, History
Zynex Inc, Key Employees
Zynex Inc, Key Employee Biographies
Zynex Inc, Key Operational Heads
Zynex Inc, Other Locations
Zynex Inc, Subsidiaries
Zynex Inc, Key Competitors
Zynex Inc, SWOT Analysis
Zynex Inc, Ratios based on current share price
Zynex Inc, Annual Ratios
Zynex Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Zynex Inc (ZYXI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Apogenix AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Apogenix AG (Apogenix) is a developer of immuno-oncology medicines for the treatment of oncological and malignant hematological diseases. The company’s pipeline drug candidates under clinical development include APG101, a CD95 ligand inhibitor for the treatment of glioblastoma and myelodyspl …
  • Alfa Laval AB (ALFA):石油・ガス:M&Aディール及び事業提携情報
    Summary Alfa Laval AB (Alfa Laval) is a provider of specialized products and solutions for heat transfer, separation and fluid handling. Its product portfolio includes centrifuges, pumps and valves, heat exchangers, thermal fluid systems, boilers, decanters, burners, evaporation systems, high speed …
  • Euskaltel SA (EKT):企業の財務・戦略的SWOT分析
    Euskaltel SA (EKT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Cotinga Pharmaceuticals Inc (COT):製薬・医療:M&Aディール及び事業提携情報
    Summary Cotinga Pharmaceuticals Inc (Cotinga), formerly Critical Outcome Technologies Inc, is a developer of targeted therapeutics with focus on oncology. The company offers pipeline products such as COTI-2 targeting p53 and COTI-259 targeting KRAS. Its research includes program, indication, screeni …
  • Noevir Holdings Co Ltd (4928):企業の財務・戦略的SWOT分析
    Noevir Holdings Co Ltd (4928) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Pan Pacific Petroleum NL Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Pan Pacific Petroleum NL Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Pan Pacific Petroleum NL Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive info …
  • Passenger Rail Agency of South Africa:企業の戦略的SWOT分析
    Passenger Rail Agency of South Africa - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • ARMO Biosciences Inc (ARMO):製薬・医療:M&Aディール及び事業提携情報
    Summary ARMO Biosciences Inc (ARMO Biosciences) is an immuno-oncology company that develops tumors treatment drugs. Its pipeline drug candidates include AM0010, AM0015, AM0012, AM0003 and AM0001. ARMO Biosciences’s lead immunotherapy AM0010 is along-acting form of recombinant human Interleukin 10 (I …
  • JBCC Holdings Inc (9889):企業の戦略的SWOT分析
    JBCC Holdings Inc (9889) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Glencore Plc:企業の戦略・SWOT・財務情報
    Glencore Plc - Strategy, SWOT and Corporate Finance Report Summary Glencore Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Kasbah Resources Limited:戦略・SWOT・企業財務分析
    Kasbah Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Kasbah Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Curtiss-Wright Corp (CW):企業の財務・戦略的SWOT分析
    Curtiss-Wright Corp (CW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Galen Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Galen Ltd (Galen), a subsidiary of Almac Group Ltd is a marketer of pharmaceutical products. The company’s products include trustsaver, calceos, salivix, daunoxome, flotros, histofreezer, laxido, and saline steripoules, among others. It offers products in various therapy areas including angi …
  • Viskase Companies Inc (VKSC):企業の財務・戦略的SWOT分析
    Viskase Companies Inc (VKSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Milliken & Company:戦略・SWOT・企業財務分析
    Milliken & Company - Strategy, SWOT and Corporate Finance Report Summary Milliken & Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Flotek Industries Inc (FTK):石油・ガス:M&Aディール及び事業提携情報
    Summary Flotek Industries Inc (Flotek) is a diversified company that develops and delivers chemistry based technology solutions for energy, industrial and consumer applications. The company offers stimulation chemistry, cementing chemistry, improved oil recovery chemistry, drilling fluid additives, …
  • Tokuyama Corp (4043):電力:M&Aディール及び事業提携情報
    Summary Tokuyama Corp (Tokuyama), formerly Nihon Soda Kogyo Co., Ltd., manufactures and sells chemicals, specialty products and cement. Its product portfolio includes soda ash, caustic soda, silicon products, vinyl chloride monomer/polymer, fine chemicals, film products, medical materials, methylene …
  • GVK Biosciences Pvt Ltd-医療機器分野:企業M&A・提携分析
    Summary GVK Biosciences Pvt Ltd (GVK BIO) is a contract research organization that offers contract manufacturing and research services. The organization provides services such as discovery services, integrated programs, clinical development, contract manufacturing, formulations and informatics. It p …
  • Banco Pan SA (BPAN4):企業の財務・戦略的SWOT分析
    Banco Pan SA (BPAN4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Johnson & Johnson Innovation – JJDC Inc:企業のM&A・事業提携・投資動向
    Johnson & Johnson Innovation - JJDC Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Johnson & Johnson Innovation - JJDC Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed re …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆